Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells
- 1 May 2009
- journal article
- Published by Elsevier in Human Immunology
- Vol. 70 (5) , 353-356
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6—STAT3 signaling pathwayProceedings of the National Academy of Sciences, 2008
- Tolerogenic Dendritic Cells: The Ins and Outs of OutcomeJournal of Immunotherapy, 2006
- STAT3: a potential therapeutic target in dendritic cells for the induction of transplant toleranceExpert Opinion on Therapeutic Targets, 2006
- Tolerization of dendritic cells by HLA‐GEuropean Journal of Immunology, 2005
- The LILR family: modulators of innate and adaptive immune pathways in health and diseaseTissue Antigens, 2004
- Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activationGene, 2004
- Dendritic cells: emerging pharmacological targets of immunosuppressive drugsNature Reviews Immunology, 2004
- High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cellsTransplant Immunology, 2003
- Pharmacologic, biologic, and genetic engineering approaches to potentiation of donorderived dendritic cell tolerogenicity1Transplantation, 2003
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002